4-52062305-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145263.4(SPATA18):c.395G>A(p.Arg132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000435 in 1,609,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145263.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA18 | NM_145263.4 | c.395G>A | p.Arg132Gln | missense_variant | 4/13 | ENST00000295213.9 | NP_660306.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA18 | ENST00000295213.9 | c.395G>A | p.Arg132Gln | missense_variant | 4/13 | 1 | NM_145263.4 | ENSP00000295213.4 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151670Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000723 AC: 18AN: 248858Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134524
GnomAD4 exome AF: 0.0000446 AC: 65AN: 1457458Hom.: 0 Cov.: 31 AF XY: 0.0000676 AC XY: 49AN XY: 725062
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151788Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74174
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2023 | The c.395G>A (p.R132Q) alteration is located in exon 4 (coding exon 4) of the SPATA18 gene. This alteration results from a G to A substitution at nucleotide position 395, causing the arginine (R) at amino acid position 132 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at